drugset / Trial / NCT00375115

Efficacy of Sambucol in the Treatment of Influenza

NCT00375115 ↗

RandomizedParallel-groupDouble-blindTreatment

Summary

The trial will examine the efficacy of sambucol in the treatment of influenza. The primary efficacy endpoint will be the length of time to resolution of influenza illness.The double blind trial will be conducted at the Personnel Clinic, and at the Clinical virology Unit, Hadassah University Hospital, and will include 100 patients with laboratory-confirmed influenza infection, 50 in the sambucol and 50 in the placebo study arm.

Timeline

Start
2006-09
Primary completion
—
Completion
2009-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Sambucol Unknown 15 ml —

Indications